-
Loading metrics
Anlotinib for refractory advanced non-small-cell lung cancer: A systematic review and meta-analysis
- Guocan Yu,
- Yanqin Shen,
- Xudong Xu,
- Fangming Zhong
![PLOS](/resource/img/logo-plos.png)
x
- Published: November 30, 2020
- https://doi.org/10.1371/journal.pone.0242982
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Loading metrics